{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T13:01:45Z","timestamp":1790600505929,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.celrep.2025.116358","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T07:33:03Z","timestamp":1759303983000},"page":"116358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["A single-dose nanoparticle vaccine protects against mpox in preclinical models"],"prefix":"10.1016","volume":"44","author":[{"given":"Run-Yu","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Bing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin-Jian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Guang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bai-Sheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9570-848X","authenticated-orcid":false,"given":"Yin-Feng","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2025.116358_bib1","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1038\/s41591-022-01907-y","article-title":"Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus","volume":"28","author":"Isidro","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2025.116358_bib3","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1038\/s41467-024-48754-8","article-title":"Longitudinal viral shedding and antibody response characteristics of men with acute infection of monkeypox virus: a prospective cohort study","volume":"15","author":"Yang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.116358_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010141","article-title":"The changing epidemiology of human monkeypox-A potential threat? A systematic review","volume":"16","author":"Bunge","year":"2022","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.celrep.2025.116358_bib5","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1099\/vir.0.81215-0","article-title":"A tale of two clades: monkeypox viruses","volume":"86","author":"Likos","year":"2005","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.celrep.2025.116358_bib6","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1038\/s41591-024-03130-3","article-title":"Sustained human outbreak of a new MPXV clade I lineage in eastern Democratic Republic of the Congo","volume":"30","author":"Vakaniaki","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2025.116358_bib7","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1080\/22221751.2022.2095309","article-title":"Monkeypox virus emerges from the shadow of its more infamous cousin: family biology matters","volume":"11","author":"Xiang","year":"2022","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.celrep.2025.116358_bib8","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nm1273","article-title":"Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypox","volume":"11","author":"Hammarlund","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2025.116358_bib9","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.cell.2016.09.049","article-title":"Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus Infections","volume":"167","author":"Gilchuk","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.116358_bib10","doi-asserted-by":"crossref","first-page":"7183","DOI":"10.1038\/s41467-025-62594-0","article-title":"Tiantan vaccinia virus-based vaccine with promising safety provides sustained protection against mpox in non-human primates","volume":"16","author":"Zhu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.116358_bib11","first-page":"192","article-title":"Protection of Rhesus Monkeys against Monkeypox by Vaccinia Virus Immunization","volume":"25","author":"McConnell","year":"1964","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.celrep.2025.116358_bib12","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1056\/NEJMra2208860","article-title":"Monkeypox","volume":"387","author":"Gessain","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2025.116358_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127598","article-title":"Current and emerging Mpox vaccine strategies: A comprehensive review","volume":"62","author":"Ortiz-Prado","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.celrep.2025.116358_bib14","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1038\/s41467-024-48180-w","article-title":"Predicting vaccine effectiveness for mpox","volume":"15","author":"Berry","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.116358_bib15","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1001\/jama.2024.21091","article-title":"Mpox Clinical Presentation, Diagnostic Approaches, and Treatment Strategies: A Review","volume":"332","author":"Titanji","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.celrep.2025.116358_bib16","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/infdis\/jiac455","article-title":"One- and Two-Dose Vaccinations With Modified Vaccinia Ankara-Bavarian Nordic Induce Durable B-Cell Memory Responses Comparable to Replicating Smallpox Vaccines","volume":"227","author":"Ilchmann","year":"2023","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.celrep.2025.116358_bib17","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1056\/NEJMoa2215201","article-title":"Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States","volume":"388","author":"Deputy","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2025.116358_bib18","article-title":"LC16m8 for Pre-exposure Prophylaxis against Mpox in a High-Risk Population: An Open-Label Randomized Trial","author":"Okumura","year":"2025","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.celrep.2025.116358_bib19","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1016\/j.vaccine.2021.08.041","article-title":"Enhanced safety surveillance study of ACAM2000 smallpox vaccine among US military service members","volume":"39","author":"Decker","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.celrep.2025.116358_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.06.021","article-title":"Vaccine effectiveness of 3rd generation mpox vaccines against mpox and disease severity: A systematic review and meta-analysis","volume":"42","author":"Pischel","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.celrep.2025.116358_bib21","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.virs.2022.07.006","article-title":"Monkeypox virus: a re-emergent threat to humans","volume":"37","author":"Gong","year":"2022","journal-title":"Virol. Sin."},{"key":"10.1016\/j.celrep.2025.116358_bib22","doi-asserted-by":"crossref","first-page":"8763","DOI":"10.1128\/JVI.00598-06","article-title":"Interaction between vaccinia virus extracellular virus envelope A33 and B5 glycoproteins","volume":"80","author":"Perdiguero","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2025.116358_bib23","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1016\/j.vaccine.2008.04.017","article-title":"Targeting the vaccinia virus L1 protein to the cell surface enhances production of neutralizing antibodies","volume":"26","author":"Golden","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.celrep.2025.116358_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105392","article-title":"Single-chain A35R-M1R-B6R trivalent mRNA vaccines protect mice against both mpox virus and vaccinia virus","volume":"109","author":"Kong","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.celrep.2025.116358_bib25","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2192815","article-title":"Rational development of multicomponent mRNA vaccine candidates against mpox","volume":"12","author":"Zhang","year":"2023","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.celrep.2025.116358_bib26","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41590-023-01715-7","article-title":"Rational design of a 'two-in-one' immunogen DAM drives potent immune response against mpox virus","volume":"25","author":"Wang","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2025.116358_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114269","article-title":"Polyvalent mpox mRNA vaccines elicit robust immune responses and confer potent protection against vaccinia virus","volume":"43","author":"Ye","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2025.116358_bib28","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1007\/s11427-023-2378-x","article-title":"Multi-valent mRNA vaccines against monkeypox enveloped or mature viron surface antigens demonstrate robust immune response and neutralizing activity","volume":"66","author":"Zhang","year":"2023","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.celrep.2025.116358_bib29","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1038\/s41467-023-41628-5","article-title":"mRNA vaccines encoding fusion proteins of monkeypox virus antigens protect mice from vaccinia virus challenge","volume":"14","author":"Hou","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.116358_bib30","doi-asserted-by":"crossref","first-page":"eadg3540","DOI":"10.1126\/scitranslmed.adg3540","article-title":"An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge","volume":"15","author":"Freyn","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2025.116358_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105668","article-title":"Mpox virus mRNA-lipid nanoparticle vaccine candidates evoke antibody responses and drive protection against the Vaccinia virus challenge in mice","volume":"216","author":"Xia","year":"2023","journal-title":"Antiviral Res."},{"key":"10.1016\/j.celrep.2025.116358_bib32","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2204151","article-title":"Mpox multi-antigen mRNA vaccine candidates by a simplified manufacturing strategy afford efficient protection against lethal orthopoxvirus challenge","volume":"12","author":"Zeng","year":"2023","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.celrep.2025.116358_bib33","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41392-023-01432-5","article-title":"Monkeypox virus quadrivalent mRNA vaccine induces immune response and protects against vaccinia virus","volume":"8","author":"Sang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.celrep.2025.116358_bib34","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.4049\/jimmunol.177.4.2552","article-title":"Subunit recombinant vaccine protects against monkeypox","volume":"177","author":"Heraud","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2025.116358_bib35","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2025.2482702","article-title":"Rational mpox vaccine design: immunogenicity and protective effect of individual and multicomponent proteins in mice","volume":"14","author":"Cheng","year":"2025","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.celrep.2025.116358_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126384","article-title":"Systematic evaluation of the induction of efficient neutralizing antibodies by recombinant multicomponent subunit vaccines against monkeypox virus","volume":"42","author":"Tan","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.celrep.2025.116358_bib37","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1128\/JVI.78.9.4433-4443.2004","article-title":"Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox","volume":"78","author":"Hooper","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2025.116358_bib38","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0042-6822(02)00038-7","article-title":"Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates","volume":"306","author":"Hooper","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.celrep.2025.116358_bib39","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1006\/viro.1999.0096","article-title":"DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge","volume":"266","author":"Hooper","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.celrep.2025.116358_bib40","doi-asserted-by":"crossref","first-page":"13454","DOI":"10.1128\/JVI.79.21.13454-13462.2005","article-title":"Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge","volume":"79","author":"Lustig","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2025.116358_bib41","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1038\/s41467-025-58180-z","article-title":"Generation and characterization of neutralizing antibodies against M1R and B6R proteins of monkeypox virus","volume":"16","author":"Qu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.116358_bib42","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1038\/s41467-024-48312-2","article-title":"Two noncompeting human neutralizing antibodies targeting MPXV B6 show protective effects against orthopoxvirus infections","volume":"15","author":"Zhao","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.116358_bib43","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.cell.2024.01.017","article-title":"A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus disease","volume":"187","author":"Zuiani","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.116358_bib44","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2025.116358_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102140","article-title":"Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: interim results of a randomised, active-controlled, observer-blinded, phase 3 trial","volume":"64","author":"Song","year":"2023","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.celrep.2025.116358_bib46","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.cell.2020.10.043","article-title":"Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2","volume":"183","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.116358_bib47","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41590-024-01776-2","article-title":"The receptor binding domain of SARS-CoV-2 Omicron subvariants targets Siglec-9 to decrease its immunogenicity by preventing macrophage phagocytosis","volume":"25","author":"He","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2025.116358_bib48","article-title":"Development of a PCSK9-targeted nanoparticle vaccine to effectively decrease the hypercholesterolemia","volume":"5","author":"Fang","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.celrep.2025.116358_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005148","article-title":"Structural and Functional Characterization of Anti-A33 Antibodies Reveal a Potent Cross-Species Orthopoxviruses Neutralizer","volume":"11","author":"Matho","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2025.116358_bib50","doi-asserted-by":"crossref","first-page":"11339","DOI":"10.1128\/JVI.01491-14","article-title":"Potent neutralization of vaccinia virus by divergent murine antibodies targeting a common site of vulnerability in L1 protein","volume":"88","author":"Kaever","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2025.116358_bib51","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2024.2401931","article-title":"Identification of mpox M1R and B6R monoclonal and bispecific antibodies that efficiently neutralize authentic mpox virus","volume":"13","author":"Ren","year":"2024","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.celrep.2025.116358_bib52","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abg1143","article-title":"A recombinant spike protein subunit vaccine confers protective immunity against SARS-CoV-2 infection and transmission in hamsters","volume":"13","author":"Wu","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2025.116358_bib53","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.4049\/jimmunol.171.10.4969","article-title":"Cutting edge: long-term B cell memory in humans after smallpox vaccination","volume":"171","author":"Crotty","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2025.116358_bib54","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/cid\/cit703","article-title":"Human monkeypox","volume":"58","author":"McCollum","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.celrep.2025.116358_bib55","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.cmi.2023.07.011","article-title":"A contemporary review of clade-specific virological differences in monkeypox viruses","volume":"29","author":"Okwor","year":"2023","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.celrep.2025.116358_bib56","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1016\/j.vaccine.2023.04.010","article-title":"Monkeypox (Mpox) requires continued surveillance, vaccines, therapeutics and mitigating strategies","volume":"41","author":"Roper","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.celrep.2025.116358_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104424","article-title":"The land-scape of immune response to monkeypox virus","volume":"87","author":"Li","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.celrep.2025.116358_bib58","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/s41591-024-03370-3","article-title":"Global genomic surveillance of monkeypox virus","volume":"31","author":"Otieno","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2025.116358_bib59","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41577-022-00775-4","article-title":"Monkeypox: disease epidemiology, host immunity and clinical interventions","volume":"22","author":"Lum","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2025.116358_bib60","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.1016\/j.cell.2024.08.043","article-title":"Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primates","volume":"187","author":"Mucker","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.116358_bib61","doi-asserted-by":"crossref","first-page":"7373","DOI":"10.1038\/s41467-025-61699-w","article-title":"A multivalent mRNA vaccine elicits robust immune responses and confers protection in a murine model of monkeypox virus infection","volume":"16","author":"Li","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.celrep.2025.116358_bib62","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.ymthe.2024.04.028","article-title":"Circular RNA vaccines against monkeypox virus provide potent protection against vaccinia virus infection in mice","volume":"32","author":"Zhou","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.celrep.2025.116358_bib63","doi-asserted-by":"crossref","first-page":"12355","DOI":"10.1128\/JVI.01593-09","article-title":"Heavily isotype-dependent protective activities of human antibodies against vaccinia virus extracellular virion antigen B5","volume":"83","author":"Benhnia","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2025.116358_bib64","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1038\/s41467-025-58328-x","article-title":"An mRNA vaccine against monkeypox virus inhibits infection by co-activation of humoral and cellular immune responses","volume":"16","author":"Tai","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.116358_bib65","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/d41573-022-00035-z","article-title":"The mRNA vaccine development landscape for infectious diseases","volume":"21","author":"Kumar","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.celrep.2025.116358_bib66","article-title":"The two-dose MVA-BN mpox vaccine induces a nondurable and low avidity MPXV-specific antibody response","volume":"99","author":"Oom","year":"2025","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2025.116358_bib67","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002843","article-title":"An engineered oncolytic vaccinia virus encoding a single-chain variable fragment against TIGIT induces effective antitumor immunity and synergizes with PD-1 or LAG-3 blockade","volume":"9","author":"Zuo","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.celrep.2025.116358_bib68","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41421-024-00739-z","article-title":"Pathogenic BALB\/c mice infection model for evaluation of mpox countermeasures","volume":"10","author":"Cheng","year":"2024","journal-title":"Cell Discov."},{"key":"10.1016\/j.celrep.2025.116358_bib69","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.immuni.2020.11.015","article-title":"Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses","volume":"53","author":"Ma","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2025.116358_bib70","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nmeth.1318","article-title":"Enzymatic assembly of DNA molecules up to several hundred kilobases","volume":"6","author":"Gibson","year":"2009","journal-title":"Nat. Methods"},{"key":"10.1016\/j.celrep.2025.116358_bib71","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0022-1759(90)90029-U","article-title":"Removal of endotoxin from protein solutions by phase separation using Triton X-114","volume":"132","author":"Aida","year":"1990","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.celrep.2025.116358_bib72","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1038\/s41467-022-30222-w","article-title":"Quadrivalent mosaic HexaPro-bearing nanoparticle vaccine protects against infection of SARS-CoV-2 variants","volume":"13","author":"Kang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.116358_bib73","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.116358_bib74","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10822-010-9352-6","article-title":"Ligand docking and binding site analysis with PyMOL and Autodock\/Vina","volume":"24","author":"Seeliger","year":"2010","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.celrep.2025.116358_bib75","article-title":"Genomic sequence and virulence of clonal isolates of vaccinia virus Tiantan, the Chinese smallpox vaccine strain","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2025.116358_bib76","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1021\/acsnano.0c08379","article-title":"Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates","volume":"15","author":"Kang","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.celrep.2025.116358_bib77","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/j.chom.2023.09.011","article-title":"A gB nanoparticle vaccine elicits a protective neutralizing antibody response against EBV","volume":"31","author":"Sun","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.celrep.2025.116358_bib78","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41586-021-04342-0","article-title":"Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta","volume":"602","author":"Ulrich","year":"2022","journal-title":"Nature"}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124725011295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124725011295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T12:47:19Z","timestamp":1790599639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124725011295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":77,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2211124725011295"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2025.116358","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A single-dose nanoparticle vaccine protects against mpox in preclinical models","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2025.116358","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116358"}}